Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz. j. med. biol. res ; 45(11): 1086-1094, Nov. 2012. ilus, tab
Article in English | LILACS | ID: lil-650571

ABSTRACT

We identified different lipemic and metabolic responses after the ingestion of a standardized meal by healthy adults and related them to atherosclerotic markers. Samples from 60 normolipidemic adults were collected before and after a liquid meal (40 g fat/m² body surface) at 0, 2, 4, 6, and 8 h for measurements of lipids, free fatty acids (FFA), insulin, cholesteryl ester transfer protein (CETP), autoantibodies to epitopes of oxidized LDL (oxLDL Ab), lipolytic activities, and apolipoprotein E polymorphism. Mean carotid intima-media thickness (cIMT) was determined by Doppler ultrasound. The volunteers were classified into early (N = 39) and late (N = 31) triacylglycerol (TAG) responders to the test meal. Late responders showed lower HDL cholesterol concentration at fasting and in the TAG peak, lower insulin and higher FFA concentrations compared to early responders. Multivariate regression analyses showed that mean cIMT was associated with gender (male) and age in early responders and by cholesterol levels at the 6th hour in late responders. oxLDL Ab were explained by lipoprotein lipase and negatively by hepatic lipase and oxLDL Ab (fasting period) by CETP (negative) and FFA (positive). This study is the first to identify a postalimentary insulin resistance state, combined with a reduced CETP response exclusively among late responders, and the identification of the regulators of postalimentary atherogenicity. Further research is required to determine the metabolic mechanisms described in the different postalimentary phenotypes observed in this study, as well as in different pathological states, as currently investigated in our laboratory.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Arteriosclerosis/etiology , Dietary Fats/administration & dosage , Arteriosclerosis/blood , Arteriosclerosis/metabolism , Body Mass Index , Biomarkers/blood , Carotid Intima-Media Thickness , Dietary Fats/metabolism , Hyperlipidemias
2.
Braz. j. med. biol. res ; 37(11): 1591-1593, Nov. 2004. tab, graf
Article in English | LILACS | ID: lil-385863

ABSTRACT

The serologic assay is an important tool in the diagnosis of leishmaniasis. One of the most commonly used tests is enzyme-linked immunosorbent assay (ELISA). Since total Leishmania promastigotes are used as antigen in the routine assay, false-positive reactions are frequent due to cross-reaction with sera from other diseases, mainly Chagas' disease. Therefore, an antigen that determines less cross-reactivity has been pursued for the serodiagnosis of leishmaniasis. In the present study we analyzed the use of recombinant Leishmania infantum heat shock protein (Hsp) 83 in ELISA for the serodiagnosis of cutaneous (N = 12) and mucocutaneous leishmaniasis (N = 14) and we observed the presence of anti-L. infantum Hsp 83 antibodies in all samples as well as anti-Leishmania total antigen antibodies. When cross-reactivity was tested, chronic Chagas' disease patients (N = 10) did not show any reactivity. Therefore, we consider this L. infantum Hsp 83 to be a good antigen for routine use for serodiagnosis of tegumentary leishmaniasis.


Subject(s)
Humans , Animals , Antibodies, Protozoan/blood , Antigens, Protozoan/blood , Heat-Shock Proteins , Leishmania infantum/immunology , Leishmaniasis, Cutaneous/diagnosis , Protozoan Proteins , Antibodies, Protozoan/immunology , Antigens, Protozoan/immunology , Case-Control Studies , Cross Reactions , Chagas Disease/diagnosis , Enzyme-Linked Immunosorbent Assay , Epitopes , Fluorescent Antibody Technique , Serologic Tests/methods
3.
Braz. j. med. biol. res ; 37(1): 119-122, Jan. 2004. ilus
Article in English | LILACS | ID: lil-352100

ABSTRACT

The introduction of highly active antiretroviral therapy (HAART) for patients infected with HIV has significantly prolonged the life expectancy and to some extent has restored a functional immune response. However, the premature introduction of HAART has led to a significant and alarming increase in cardiovascular complications, including myocardial infarction and the appearance of abnormal distribution of body fat seen as lipodystrophy. One key element in the development of ischemic coronary artery disease is the presence of circulating and tissue-fixed modified low density lipoprotein (mLDL) that contributes to the initiation and progression of arterial lesions and to the formation of foam cells. Even though not completely elucidated, the most likely mechanism involves mLDL in the inflammatory response and the induction of a specific immune response against mLDL. Circulating antibodies against mLDL can serve as an indirect marker of the presence of circulating and vessel-fixed mLDL. In the present study, we measured antibodies to mLDL and correlated them with immune status (i.e., number of CD4+ T cells) in 59 HIV patients and with the clinical manifestation of lipodystrophy in 10 patients. We observed a significant reduction in anti-mLDL antibody levels related both to lipodystrophy and to an immunocompromised state in HIV patients. We speculate that these antibodies may explain in part the rapid development of ischemic coronary artery disease in some patients.


Subject(s)
Humans , Coronary Disease , HIV Infections , Lipodystrophy , Lipoproteins, LDL , Autoantibodies , Biomarkers , CD4 Lymphocyte Count , Coronary Disease , Enzyme-Linked Immunosorbent Assay , HIV Infections , Lipodystrophy , Lipoproteins, LDL , Risk Factors
4.
Braz. j. med. biol. res ; 36(4): 491-494, Apr. 2003. ilus, tab
Article in English | LILACS | ID: lil-331225

ABSTRACT

Hormone replacement therapy (HRT) reduces cardiovascular risks, although the initiation of therapy may be associated with transient adverse ischemic and thrombotic events. Antibodies against heat shock protein (Hsp) and oxidized low density lipoprotein (LDL) have been found in atherosclerotic lesions and plasma of patients with coronary artery disease and may play an important role in the pathogenesis of atherosclerosis. The aim of the present study was to assess the effects of HRT on the immune response by measuring plasma levels of antibodies against Hsp 65 and LDL with a low and high degree of copper-mediated oxidative modification of 20 postmenopausal women before and 90 days after receiving orally 0.625 mg equine conjugate estrogen plus 2.5 mg medroxyprogesterone acetate per day. HRT significantly increased antibodies against Hsp 65 (0.316 ± 0.03 vs 0.558 ± 0.11) and against LDL with a low degree of oxidative modification (0.100 ± 0.01 vs 0.217 ± 0.02) (P<0.05 and P<0.001, respectively, ANOVA). The hormone-mediated immune response may trigger an inflammatory response within the vessel wall and potentially increase plaque burden. Whether or not this immune response is temporary or sustained and deleterious requires further investigation


Subject(s)
Humans , Female , Middle Aged , Autoantibodies , Heat-Shock Proteins , Hormone Replacement Therapy , Lipoproteins, LDL , Medroxyprogesterone Acetate , Postmenopause , Analysis of Variance , Autoantibodies , Postmenopause
5.
Braz. j. med. biol. res ; 33(3): 313-6, Mar. 2000. tab, ilus
Article in English | LILACS | ID: lil-255051

ABSTRACT

The uptake of lipids and lipoprotein particles by macrophages undergoes phagocytic activation and the formation of foam cells are key events in atherosclerosis. In this study we determined how intact high density lipoproteins (HDL) and apolipoproteins-HDL (removal of the lipid component from HDL, i.e., apoHDL) influence the phagocytosis of zymosan by mouse peritoneal macrophages. Zymosan particles preincubated together with lipoproteins or alone (control) were incubated with the macrophages. Phagocytosis activity was reported as the percent of macrophages that internalized three or more zymosan particles. HDL co-incubated with zymosan did not influence the over-all uptake of zymosan particles compared to apoHDL, which greatly enhanced the ability of the particle to be phagocytized (P<0.001). Part of this effect might be related to a greater binding of apoHDL to the particles compared to that of HDL (P<0.05). We conclude that this can be a useful method to study the ability of lipoproteins, including modified lipoproteins obtained from subjects with genetic forms of hyperlipidemia, to opsonize particles such as red blood cells and thus to investigate the processes that control the formation of foam cells and the mechanisms of atherogenesis.


Subject(s)
Animals , Mice , Apolipoproteins/physiology , Lipoproteins, HDL/physiology , Macrophages, Peritoneal/physiology , Phagocytosis/physiology , Zymosan/physiology , Atherosclerosis/physiopathology
6.
Braz. j. med. biol. res ; 32(3): 323-5, Mar. 1999.
Article in English | LILACS | ID: lil-230460

ABSTRACT

In order to study the role of natural killer (NK) cells during the early period of Leishmania infection, BALB/c mice were selectively and permanently depleted of NK cells by injection with 90Sr and subsequently infected with Leishmania (Leishmania) amazonensis (HSJD-1 strain). 90Sr is known to selectively deplete NK cells, leaving an intact T- and B-cell compartment and preserving the ability to produce both interferon alpha and IL-2. This method of depletion has advantages when compared with depletion using anti-NK cell monoclonal antibodies because the effect is permanent and neither activates complement nor provokes massive cell death. In the present study, after one month of treatment with 90Sr, the depletion of NK cells was shown by a more than ten-fold reduction in the cytotoxic activity of these cells: 2 x 106 spleen cells from NK-depleted animals were required to reach the same specific lysis of target cells effected by 0.15 x 106 spleen cells from normal control animals. The histopathology of the skin lesion at 7 days after Leishmania infection showed more parasites in the NK cell-depleted group. This observation further strengthens a direct role of NK cells during the early period of Leishmania infection


Subject(s)
Animals , Mice , Killer Cells, Natural/radiation effects , Leishmaniasis, Cutaneous/radiotherapy , Strontium Radioisotopes/therapeutic use , Interferon-alpha/biosynthesis , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/radiotherapy , Lymphocyte Depletion , Mice, Inbred BALB C , Strontium Radioisotopes/therapeutic use
7.
Braz. j. med. biol. res ; 29(12): 1625-8, Dec. 1996. graf
Article in English | LILACS | ID: lil-188444

ABSTRACT

Oxidative processes leading to the generation of oxidized low density lipoprotein (oxLDL) particles have been suggested to be an important factor in the pathogenesis of atherosclerosis. After initiation of the oxidative process, LDL undergoes a progressive protein and lipid fragmentation. To understand this process and the role of oxLDL in various diseases of inflammatory origin, we have generated mouse monoclonal antibodies against copper-oxidized human LDL. Mice were immunized intrasplenically and after one intravenous boost the spleen cells were fused with the Sp2/0 hybridoma fusion partner. The hybridoma clones obtained after selection and cloning were analyzed for reactivity against oxLDL with various degrees of copper-mediated oxidative modifications. Three hybridoma clones were purified and further characterized. The following observations were made: 1) the intrasplenic route of immunization, avoiding the use of mycobacterial adjuvants, yielded a high frequency of positive clones; 2) the individual hybridomas reacted against LDL with various degrees of oxidative modifications; 3) the monoclonal antibodies could be used in ELISA and to detect oxLDL in immunohistochemical tissue staining, and 4) the monoclonal antibodies also detected oxLDL from hamsters and rabbits. We conclude that these monoclonal antibodies could be useful to further investigate the role of oxLDL in inflammation and in the immune response.


Subject(s)
Mice , Animals , Antibodies, Monoclonal , Lipoproteins, LDL/immunology , Oxidative Stress , Atherosclerosis/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL